-
Cost-Effectiveness of Peripheral Neuropathy Screening in Malaysian Adults With Thalassemia: An Integrated Modeling Approach
Sep 9, 2025, 16:22 PM -
Inefficiencies in Developing UK and Irish HTA Submissions and How to Streamline the Process
Sep 9, 2025, 16:22 PM -
Patient Access Delays for Subsequent Indications of Multi-indication Treatments: An Assessment of Health Technology Assessment Decision Making
Sep 9, 2025, 16:22 PM -
Costs and Health Outcomes of Meek Skin Micrografting vs. Mesh Skin Grafting in Adult Patients With Deep Partial Thickness and/or Full-Thickness Small (Burn) Wounds
Sep 9, 2025, 16:22 PM -
Towards Quantifying the Impact of Hypofractionation vs. Standard Radiotherapy Treatment Regimens for Cancer on Costs Workflow and the Environment
Sep 9, 2025, 16:22 PM -
The Role of Lifestyle in the Development of Fertility Issues
Sep 9, 2025, 16:22 PM -
The Clinical, Humanistic and Economic Burden of the Management of Patients With Recurrent Malignant Ascites in the UK and Europe
Sep 9, 2025, 16:22 PM -
Market Access AI Readiness: Maximizing Strategic Alignment Through Organizational Insights
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Contemporary First-Line (1L) Treatments for Locally Advanced or Metastatic Urothelial Carcinoma La/mUC in France: A Sensitivity Analysis
Sep 9, 2025, 16:22 PM -
Spain Leveling Up: A Comparison of Spain’s New National Health Economic Evaluation Guideline With Those of England, France, Germany, Italy, Portugal, Sweden, Ireland, Canada, Australia, and Japan
Sep 9, 2025, 16:22 PM -
Are We SEEing It Yet? The Use of Structured Expert Elicitation Protocols for Decision Making
Sep 9, 2025, 16:22 PM -
Healthstate Utilities for Hormone Receptor-Positive (HR+) Human Epidermal Growth Factor-Receptor 2 Negative (HER2-) Breast Cancer
Sep 9, 2025, 16:22 PM -
Evolution of Utilization and Costs of Long-Acting Injectable Antipsychotics (LAIs) in Outpatient Care at Lisbon Psychiatric Hospital (March-May 2022 vs. 2025)
Sep 9, 2025, 16:22 PM -
Evaluating the Impact of Different Payment Models on the Cost-Effectiveness and Budget Impact of Cell and Gene Therapies: Eladocagene Exuparvovec As a Case Study
Sep 9, 2025, 16:22 PM -
Societal Burden of Specific Learning Disorders With Focus on Secondary Mental Health Problems in Japan
Sep 9, 2025, 16:22 PM -
FLAME: An Open-Source Federated Platform for Deeply Phenotyped and Multimodal Studies at Population Scale
Sep 9, 2025, 16:22 PM -
HDX vs. HDF in End-Stage Kidney Disease: Cost-Minimization Study in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Modeling the Clinical and Economic Impact of DPP-4 Inhibitors in Uncontrolled T2D
Sep 9, 2025, 16:22 PM -
Spillover Effect in Health Utility Values: A Systematic Review
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Different Crown Materials for Dental Prosthesis From Budget in Wartime in Ukraine
Sep 9, 2025, 16:22 PM
